Video

On Cancer: Meet Leukemia Expert Virginia Klimek

By Memorial Sloan-Kettering | Monday, July 22, 2013

Internist and medical oncologist Virginia Klimek discusses the importance of research, clinical trials, and patient education in finding new treatments for myelodysplastic syndromes (MDS).

Comments

Submitted by Memorial Sloan-Kettering | Friday, July 26, 2013 - 8:12 AM.

Alex, Para hacer una cita o coordinar una revisión de sus registros médicos con uno de nuestros médicos, puede comunicarse con el Centro Internacional del Memorial Sloan-Kettering Cancer Center. Puede mandar un mensaje por correo electrónico: intnlprg@mskcc.org, o puedes llamar por teléfono usando el servicio de acceso directo de AT&T. Primero marque el número de acceso del país en que está , luego 888-675-7722. Aquí le envío la página electrónica de nuestro Centro Internacional con más información: http://es.mskcc.org/cancer-care/international-patients Gracias por su comentario.

Submitted by Leon Socol | Wednesday, August 14, 2013 - 9:59 AM.

My wife died of MDS in Sept. 2011 at age 79. She was treated at the Winship Cancer Institute of Emory University in Atlanta. She underwent many blood infusions and some injections. There was hope that a bone marrow transplant would provide a positive, but the doctors said she was not a candidate because of her age. I understand there is research going on to make the bone marrow transplants more receptive and eliminate the conditions of rejection and other complications. Too late for my wife, but I'd like to be kept updated on progress in MDS research by Sloan Kettering.